Women Fare Poorly With Aortic Aneurysm: Study
WEDNESDAY, April 26, 2017 -- Women with abdominal aortic aneurysms have far worse outcomes than men, and their treatment needs to be dramatically improved, British researchers report.
An abdominal aortic aneurysm occurs when there is weakening and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 26, 2017 Category: Journals (General) Source Type: news
Women Fare Poorly With Aortic Aneurysm: Study
Title: Women Fare Poorly With Aortic Aneurysm: StudyCategory: Health NewsCreated: 4/26/2017 12:00:00 AMLast Editorial Review: 4/26/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - April 26, 2017 Category: Cardiology Source Type: news
Women with aortic aneurysms fare much worse than men, new study finds
(Imperial College London) Mortality rates for women undergoing surgery for abdominal aortic aneurysms are nearly twice those for men, a new study has found. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 25, 2017 Category: Global & Universal Source Type: news
MassDevice.com +5 | The top 5 medtech stories for April 5, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Trumpcare’s prospects dim, but not too dim to hit stent graft makers
The push on Capitol Hill to revive Trumpcare stalled yesterday, but not before the chatter out of Washington instigated a slide for stent graft makers’ st...
Source: Mass Device - April 5, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Trumpcare ’ s prospects dim, but not too dim to hit stent graft makers
The push on Capitol Hill to revive Trumpcare stalled yesterday, but not before the chatter out of Washington instigated a slide for stent graft makers’ stocks.
The Affordable Care Act covers a 1-time screening for abdominal aortic aneurysms in men who smoke or smoked in the past, listing the test as an “essential health benefit.”
The GOP’s healthcare reform proposal would do away with the AAA screening coverage, shifting the cost of the test to patients, which could in turn affect AAA repair procedure volumes. Investors reacted by pushing share prices down yesterday on Wall Street for Lombard Medic...
Source: Mass Device - April 5, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Healthcare Reform Stent Grafts Wall Street Beat C.R. Bard Capitol Hill Endologix Lombard Medical Technologies Source Type: news
7 medtech stories we missed this week: March 31, 2017
[Image from unsplash.com]This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia.
Here are 7 medtech stories we missed this week but thought were still worth mentioning:
1. Corindus touts first Asian use of next-generation robot
Corindus Vascular Robotics announced in a March 31 press release that robot-assisted PCI procedures were performed for the first time in Asia using the CorPath GRX system. The procedures were performed at Fu Wai Hospital. This is the first time the system has been used outside of the U.S. CorPath GRX enhances the precision and workflow of the...
Source: Mass Device - March 31, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Food & Drug Administration (FDA) Robot-Assisted Surgery Robotics Stent Grafts Amniox Bodycad Corindus Endologix MedTech NeoSurgical NeoTract Providence Medical Tissuetech Source Type: news
Moderate drinking may reduce heart disease risk
Conclusion
This study paints a more complicated picture than the "Pint a day keeps the doctor away" story proffered by The Sun.
It seems to confirm the findings of other studies, which have shown that non-drinkers tend to have a higher risk of cardiovascular diseases than people who drink moderately.
It suggests that some cardiovascular diseases (mainly those directly affecting the heart) seem to have a stronger link to a possible protective effect from alcohol than other vascular diseases, such as mini-strokes and bleeding in the brain. However, this can't be concluded with certainty due to the study design.
We ...
Source: NHS News Feed - March 23, 2017 Category: Consumer Health News Tags: Heart/lungs Food/diet Lifestyle/exercise Source Type: news
Endologix faces shareholder suit over Nellix snafu
Endologix (NSDQ:ELGX) is facing a lawsuit from stockholders alleging the company miscommunicated and failed to disclose issues related to its Nellix EVAS stent graft designed for treating abdominal aortic aneurysms.
The shareholders filed the suit in the US District Court for the Central District of California, representing individuals who purchased shares between Aug. 2, 2016 and Nov. 16, 2016, according to an SEC filing.
The suing shareholders allege that the company made “materially false and misleading statements and failed to disclose material adverse facts about its business, operational and financial performa...
Source: Mass Device - March 3, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Legal News Endologix Inc. Source Type: news
MicroPort, undaunted by price caps, enters India ’ s stent market
MicroPort has entered the Indian market only days after the country’s National Pharmaceutical Pricing Authority imposed a price cap on coronary stents.
The Shanghai-based company said its Firehawk Rapamycin target eluting coronary stent system was successfully used in a procedure in Mumbai earlier in the month, marking the 1st time the device saw use in the country.
The procedure was performed at H. J. Doshi Ghatkopar Hindu Sabha Hospital in Mumbai, by Dr. Anil Potdar, according to a press release. The company touted the Indian market as having the 3rd largest amount of PCI cases in the world, and promised future expansi...
Source: Mass Device - February 28, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiac Implants Cardiovascular Stents MicroPort Scientific Source Type: news
Endologix wins CE Mark reinstatement for AFX, AFX2, touts 3-year post market Ovation study
This study confirms the ability of the Ovation platform to successfully treat a broad array of patient anatomies with a high rate of treatment success and freedom from secondary intervention through mid-term follow-up. We are pleased to have revealed these impressive results at our scientific symposium this year,” study principal investigator Dr. Dierk Scheinert said in a prepared statement.
“The addition of these European results continue to validate the excellent clinical results and durability of the ultra-low profile Ovation platform, further confirming the recently announced 5-year Ovation IDE study resul...
Source: Mass Device - January 25, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Regulatory/Compliance Vascular Endologix Inc. Source Type: news
Endologix cuts outlook for 2017
Endologix is reportedly lowering its revenue growth outlook to flat- to low-single digits. The company has previously said it expects mid-single digit growth for 2017.
The Irvine, Calif.-based company’s management commented on Endologix’s outlook at the 35th JP Morgan Healthcare Conference, according to a report from Leerink.
The company has not made a formal statement regarding its guidance for 2017.
The analyst wrote that Endologix is probably going to see further downward estimate revisions, especially given the regulatory and quality issues that came to light in December last year.
The company put a temp...
Source: Mass Device - January 11, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: MassDevice Earnings Roundup Vascular Wall Street Beat Endologix Inc. Source Type: news
Lombard wins Japanese clearance for IntelliFlex LP delivery device for Aorfix stent graft
Lombard Medical Technologies (NSDQ:EVAR) said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its Intelliflex low profile delivery system for the Aorfix endovascular stent graft.
The Oxfordshire, England-based company said it will initiate a commercial launch of the device in Japan once it receives reimbursement approval, expected some time next month. Currently, Medico’s Hirata has exclusive distribution rights to the Aorfix.
“We have enjoyed great success already with Aorfix in Japan and built our market share to approximately 8% over the last two years. Now with the appro...
Source: Mass Device - January 5, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Regulatory/Compliance Vascular Lombard Medical Technologies Source Type: news
MassDevice.com +5 | The top 5 medtech stories for December 28, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Precision Spine wins FDA 510(k) for AccuFit lateral plate system
Precision Spine said today it won FDA 510(k) clearance for its AccuFit lateral plating system designed to treat spinal instability.
The Parsippany, N.J.-based com...
Source: Mass Device - December 28, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Endologix puts hold on AFX shipments over manufacturing issues
Endologix (NSDQ:ELGX) said today it is temporarily holding shipments of its AFX Endovascular abdominal aortic aneurysm system as it completes an investigation of manufacturing issues with the devices.
The AFX system is designed to provide anatomical fixation to treat a wide range of AAA anatomies, according to the company.
The hold came only weeks after Endologix had the CE Mark approval for the AFX system suspended over reports of type III endoleaks associated with a previous-gen version of the device.
The Irvine, Calif.-based company expects the temporary hold to be lifted for some sizes “in the near future,”...
Source: Mass Device - December 27, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Regulatory/Compliance Vascular Endologix Inc. Source Type: news
China ’ s Microport puts $15m into Lombard Medical
Lombard Medical Technologies (NSDQ:EVAR) said today that China’s MicroPort Orthopedics invested $15 million as part of a partnership deal between the 2 companies.
Through the partnership, Lombard will seek to accelerate commercialization of its Arofix and Altura stent grafts for treating abdominal aortic aneurysms. Microport will gain exclusive marketing rights for both products in China and Brazil, as well as a license to manufacture the products for the Chinese market.
As part of the deal, Microport and Lombard said they entered a component supply manufacturing deal, with Microport manufacturing components for t...
Source: Mass Device - December 19, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Mergers & Acquisitions Stent Grafts Vascular Lombard Medical Technologies MicroPort Scientific Source Type: news
